Related posts:

1. Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
2. Saliva Analysis Reveals Decision-Making Skills Saliva Analysis Reveals Decision-Making Skills ...
3. California’s Role In Ensuring That The Potential Of Health Reform Becomes Reality The fifty states will play a critical role in implementing the Affordable Care Act, and California is one of the states at the forefront of reform. The act can provide coverage to millions of currently uninsured Californians and offers important benefits in terms of more-affordable coverage, improved access to services, and better health outcomes. As […]...
4. Share of Cost, Brain training induces lasting brain and mental health gains for veterans, civilians with brain injury Share of Cost, Brain training induces lasting brain and mental health gains for veterans, civilians with brain injury...
5. First Patient Enrolled And Treated In The U.S. For EndoGastric Solutions’ Randomized Study Of Transoral Incisionless Fundoplication (TIF) EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the first patient has been enrolled and treated in the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial). The RESPECT trial was designed by co-principle investigators Dr. John Hunter, Chairman of Surgery, Oregon Health & Science University, and […]...
6. Share of Cost, Therapy Crosses Blood-Brain Barrier to Treat Neurological Disease Share of Cost, Therapy Crosses Blood-Brain Barrier to Treat Neurological Disease ...
7. Study Shows Promise For New Drug To Treat Fragile X Study Shows Promise For New Drug To Treat Fragile X...
8. New Breathing Therapy Reduces Panic And Anxiety By Reversing Hyperventilation New Breathing Therapy Reduces Panic And Anxiety By Reversing Hyperventilation...
9. Seaside Therapeutics Initiates Phase 2b Study Of STX209 In Autism Spectrum Disorders Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 2b study to evaluate the effects of STX209 (arbaclofen) on social impairment in children, adolescents and adults (ages 5 to 21) with autism spectrum disorders (ASD). The Company announced positive results from an open-label Phase 2a study of STX209 in September of […]...
10. Share of Cost, Researchers find potential target for drug to treat allergic asthma Share of Cost, Researchers find potential target for drug to treat allergic asthma...
11. Share of Cost, Diabetes patients cope better when they have a positive outlook and social support Share of Cost, Diabetes patients cope better when they have a positive outlook and social support...
12. Employers Still Excluding Large Groups of People from Jobs Based on Race, Sex, Age & Disability Experts testified at a U.S. Equal Employment Opportunity Commission (EEOC) meeting that employers nationwide continue to discriminate against job seekers based on their race, sex, age, national origin, disability or other prohibited bases. An EEOC trial attorney described the case of two deaf applicants who were denied employment by Walmart because they were deaf. The public can submit written comments by mail […]...
13. Share of Cost, Burnout In Middle-Aged Women Share of Cost, Burnout In Middle-Aged Women...
14. Share of Cost, New Health Care Rule Gives Consumers Better Ways to Compare Health Care Options in 2014 Share of Cost, New Health Care Rule Gives Consumers Better Ways to Compare Health Care Options in 2014...
15. Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders...